MedTrace Logo

Clinical Characteristics and Outcomes Among STEMI Patients With Cardiogenic Shock at Abu Dhabi City

NCT06535503 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 400

Last updated 2025-02-17

No results posted yet for this study

Summary

A retrospective study on the clinical characteristics and treatment outcomes of patients admitted with ST-elevation Myocardial Infarction (STEMI) complicated with cardiogenic shock (CS) during admission or CS development during their hospital stay for two tertiary hospitals in Abu Dhabi, UAE, from 2020-2024.

Conditions

  • ST Elevation Myocardial Infarction
  • Cardiogenic Shock

Sponsors & Collaborators

  • Sheikh Shakhbout Medical City

    collaborator OTHER

  • Sheikh Khalifa Medical City

    collaborator OTHER

  • Abu Dhabi Health Services Company

    lead OTHER_GOV

Principal Investigators

  • Abdulmajeed BS Alzubaidi, MD · Abu Dhabi Health Services Co. -SEHA

  • Babiker Babiker Mohamed Babiker Elsiraj MB Elsiraj · Sheikh Shakhbout Medical City

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2024-07-01
Primary Completion
2025-01-01
Completion
2025-05-30

Countries

  • United Arab Emirates

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06535503 on ClinicalTrials.gov